ログイン

ISBB

ISBB
100問 • 1年前
  • Yves Laure Pimentel
  • 通報

    問題一覧

  • 1

    Blood films for malaria * 0/1 A. Thin film should be fixed with methanol B. Thick film should be fixed with methanol C. Neither A or B D. Both a and b

    A. Thin film should be fixed with methanol

  • 2

    A patient showed positive results with screening cells and 4 donor units. The patient autocontrol was negative. What is the most likely antibody? * 0/1 A. Anti-H B. Anti-S C. Anti-Kpa D. Anti-k

    D. Anti-k

  • 3

    HDFN is nearly always limited to A or B infants of group ___ mothers * 0/1 A. A B. B C. O D. AB

    C. O

  • 4

    Most common cause of HDFN * 0/1 A. Rh Antibody B. ABO antibody C. Duffy Antibody D. Kell Antibody

    B. ABO antibody

  • 5

    Most lethal cause of HDFN * 1/1 A. Rh Antibody B. ABO antibody C. Duffy Antibody D. Kell Antibody

    A. Rh Antibody

  • 6

    What minor blood group has a complement? * 0/1 A. Chido-rodgers B. Knops C. Vel D. AOTA

    A. Chido-rodgers

  • 7

    What protein who is also an APR needed for coagulation of blood? * 0/1 A. Thrombin B. Fibrinogen C. Ceruloplasmin D. Haptoglobin

    B. Fibrinogen

  • 8

    Your mother is a breast cancer patient, what tumor marker should be used? * 1/1 A. CEA B. CYFRA C. CA 153 D. CA 199

    C. CA 153

  • 9

    How many diluent is needed if you have 0.2 ml of solute with a 1:20 dilution? * 0/1 A. 19.8 B. 3.8 C. 4 D. 1.8

    B. 3.8

  • 10

    What IgG subclass that is the most abundant? * 1/1 A. IgG1 B. IgG2 C. IgG3 D. IgG4

    A. IgG1

  • 11

    Cancer remission * 1/1 A. Accept B. Retest C. Defer D. Take history

    C. Defer

  • 12

    Type of Anti D except * 1/1 a. IgG b. IgM c. IgA d. IgE

    d. IgE

  • 13

    It is the most common parasitic complication of transfusion * 0/1 a. babesiosis b. malaria c. chaga d. toxoplasmosis

    b. malaria

  • 14

    P1 is considered as * 0/1 a. IgG b. IgM c. IgA d. IgE

    b. IgM

  • 15

    All of the following is required of HIV testing, except * 1/1 a. TB px b. all infants c. px w/ std d high risk population

    b. all infants

  • 16

    What should be done if you observe the stop in the flow of blood during blood donation * 1/1 A. Reposition the needle B. Draw 2nd sample C. Stop the donation D. Squeeze the line

    A. Reposition the needle

  • 17

    From the following, identify a specific component of the adaptive immune system that is formed in response to antigenic stimulation: * 0/1 a) Lysozyme b) Complement c) Commensal organisms d) Immunoglobulin

    d) Immunoglobulin

  • 18

    Which cluster of differentiation (CD) marker appears during the first stage of T-cell development and remains present as an identifying marker for T cells? * 1/1 a) CD1 b) CD2 c) CD3 d) CD4 or CD8

    b) CD2

  • 19

    All of the following are immunologic functions of complement except: * 0/1 a) Induction of an antiviral state b) Opsonization c) Chemotaxis d) Anaphylatoxin formation

    a) Induction of an antiviral state

  • 20

    Which serum antibody response usually characterizes the primary (early) stage of syphilis? * 1/1 a) Antibodies against syphilis are undetectable b) Detected 1–3 weeks after appearance of the primary chancre c) Detected in 50% of cases before the primary chancre disappears d) Detected within 2 weeks after infection

    b) Detected 1–3 weeks after appearance of the primary chancre

  • 21

    Which tests are considered screening tests for HIV? * 1/1 a) ELISA, 4th generation, and rapid antibody tests b) Immunofluorescence, Western blot, radioimmuno-precipitation assay c) Culture, antigen capture assay, DNA amplification d) Reverse transcriptase and messenger RNA (mRNA) ass

    a) ELISA, 4th generation, and rapid antibody tests

  • 22

    Interpret the following results for HIV infection. ELISA: positive; Repeat ELISA: negative; Western blot: no bands * 1/1 a) Positive for HIV b) Negative for HIV c) Indeterminate d) Further testing needed

    b) Negative for HIV

  • 23

    Which CD4:CD8 ratio is most likely in a patient with AIDS? * 1/1 a) 2:1 b) 3:1 c) 2:3 d) 1:2

    d) 1:2

  • 24

    What should be done if all forward and reverse ABO results as well as the autocontrol are positive? * 1/1 a) Wash the cells with warm saline, autoadsorb the serum at 4oC b) Retype the sample using a different lot number of reagents c) Use polyclonal typing reagents d) Report the sample as group AB

    a) Wash the cells with warm saline, autoadsorb the serum at 4oC

  • 25

    The k (Cellano) antigen is a high-frequency antigen and is found on most red cells. How often would one expect to find the corresponding antibody? * 1/1 a) Often b) Rarely c) Always d) Never

    b) Rarely

  • 26

    Which of the following is not a requirement for the electronic crossmatch? * 1/1 a) The computer system contains logic to prevent assignment and release of ABO incompatible blood b) There are concordant results of at least two determinations of the recipient’s ABO type on record, one of which is from the current sample c) Critical elements of the system have been validated on site d) There are concordant results of at least one determination of the recipient’s ABO type on file

    d) There are concordant results of at least one determination of the recipient’s ABO type on file

  • 27

    What ABO types may donate to any other ABO type? * 1/1 a) O- b) A-, O- c) A- d) A-,B-,AB-,O-

    a) O-

  • 28

    A major crossmatch and screening cells are 2+ at IS, 1+ at 37°C, and negative at the IAT phase. Identify the most likely problem. * 1/1 a) Combination of antibodies b) Cold alloantibody c) Rouleaux d) Test error

    b) Cold alloantibody

  • 29

    All of the following are reasons for performing an adsorption, except: * 0/1 a) Separation of mixtures of antibodies b) Removal of interfering substances c) Confirmation of weak antigens on red cells d) Identification of antibodies causing a positive DAT

    d) Identification of antibodies causing a positive DAT

  • 30

    When may an immediate spin crossmatch be performed? * 0/1 a) When a patient is being massively transfused b) When there is no history of antibodies and the current antibody screen is negative c) When blood is being emergency released d) When a patient has not been transfused in the past 3 months

    b) When there is no history of antibodies and the current antibody screen is negative

  • 31

    Which of the following vaccinations carries no deferral period? * 1/1 a) Rubella b) Varicella zoster c) HPV d) Small pox

    c) HPV

  • 32

    What should be done when a woman who is 24 weeks pregnant has a positive antibody screen? * 0/1 a) Perform an antibody identification panel; titer if necessary b) No need to do anything until 30 weeks gestation c) Administer Rh immune globulin (RhIg) d) Adsorb the antibody onto antigen-positive cells

    a) Perform an antibody identification panel; titer if necessary

  • 33

    What is the latest method used in detecting HIV infection in its early acute phase? * 1/1 a) ELISA b) Southern Blot c) Western blot d) Nucleic acid amplification testing

    d) Nucleic acid amplification testing

  • 34

    Who is the best candidate for a predeposit autologous donation? * 1/1 a) A 45-year-old man who is having elective surgery in 2 weeks; he has alloanti-k b) A 23-year-old female leukemia patient with a hemoglobin of 10 g/dL c) A 12-year-old boy who has hemophilia d) A 53-year-old woman who has septicemia

    a) A 45-year-old man who is having elective surgery in 2 weeks; he has alloanti-k

  • 35

    ANA tests are performed to help diagnose which condition: * 1/1 a) SLE b) Rheumatoid arthritis c) Leukemia d) Hemolytic anemia

    a) SLE

  • 36

    To make a presumptive diagnosis of RA, which of the following qualitative methods is MOST sensitive * 0/1 a) Latex agglutination b) Immunoelectrophoresis c) RID d) ELISA

    a) Latex agglutination

  • 37

    In chronic active hepatitis, high titers of which of the following antibodies are seen? * 1/1 a) Anti-smooth muscle b) Antimitochondrial c) Anti-DNA d) Anti-parietal cell

    a) Anti-smooth muscle

  • 38

    Anti-glomerular basement membrane antibody is MOST often associated with this condition: * 1/1 a) Goodpasture disease b) SLE c) Celiac disease d) Chronic active hepatitis

    a) Goodpasture disease

  • 39

    Flocculation tests for syphilis detect the presence of * 1/1 a) Reagin b) Antigen c) Hemolysin d) Forssman antigen

    a) Reagin

  • 40

    Which of the following is a treponemal test? * 1/1 a) RST b) RPR c) FTA-ABS d) VDRL

    c) FTA-ABS

  • 41

    The key structural difference that distinguishes immunoglobulin subclasses: * 0/1 a) Stereometry of the hypervariable region b) Number of domains c) Sequence of the constant regions d) Number of disulfide bridges

    c) Sequence of the constant regions

  • 42

    Antibody idiotype is dictated by the * 0/1 a) Constant region of heavy chain b) Constant region of light chain c) Constant regions of heavy and light chains d) Variable regions of heavy and light chains

    d) Variable regions of heavy and light chains

  • 43

    Immunoglobulin that is most efficient at crossing the placenta: * 1/1 a) IgG b) IgA c) IgM d) IgD

    a) IgG

  • 44

    Which is most likely to activate the alternative pathway * 0/1 a) Lipopolysaccharide b) Glycoproteins c) Haptens d) IgG complexed with antige

    a) Lipopolysaccharide

  • 45

    T lymphocytes are incapable of functioning as: * 0/1 a) Cytotoxic cells b) Helper cells c) Phagocytic cells d) Regulatory cells

    c) Phagocytic cells

  • 46

    Which test is used to evaluate the cellular immune system in a patient? * 0/1 a) Skin test for commonly encountered antigens b) Determination of isohemagglutinin titer c) Immunoelectrophoresis of serum d) Measurement of anti-HBsAg after immunization

    a) Skin test for commonly encountered antigens

  • 47

    Tumor markers found in the circulation are most frequently measured by: * 1/1 a) Immunoassays b) TLC c) HPLC d) Colorimetry

    a) Immunoassays

  • 48

    Antigen receptors on T lymphocytes bind HLA class II molecules with the help of which accessory molecule? * 0/1 a) CD2 b) CD3 c) CD4 d) CD8

    c) CD4

  • 49

    Bone marrow transplant donors and their recipients must be matched for which antigen systems * 0/1 a) ABO & Rh b) HLA c) CD4/CD8 d) P

    b) HLA

  • 50

    Which antibody characteristically gives a refractile mixed-field appearance? * 1/1 a) Anti-K b) Anti-Dia c) Anti-Sda d) Anti-s

    c) Anti-Sda

  • 51

    What does a minor crossmatch consist of? * 1/1 a) Recipient plasma and recipient red cells b) Recipient plasma and donor red cells c) Recipient red cells and donor plasma d) Donor plasma and donor red cells

    c) Recipient red cells and donor plasma

  • 52

    Most common Di phenotype is often associated with what ancestry: * 0/1 a) Asian b) African c) European d) Mongolian

    d) Mongolian

  • 53

    A 47-year old man with a history of cancer wants to donate blood. What would the MTOD do? * 0/1 a) Defer b) Defer for 1 year c) Defer for 3 years d) Accept

    a) Defer

  • 54

    Symptoms of dyspnea, cough, hypoxemia, and pulmonary edema within 6 hours of transfusion: * 0/1 a) Anaphylactic b) Hemolytic c) TRALI d) TACO

    c) TRALI

  • 55

    Which is NOT a correct match of blood component and its temperature? * 0/1 a) Frozen RBCs: -18°C b) Platelets: 20-24°C c) FFP: -65 d) Cryoprecipitate: -18°C

    a) Frozen RBCs: -18°C

  • 56

    The anticoagulant/s with the shelf life of 21 days: 1. CPD 2. CPDA-1 3. CP2D 4. ACD 5. ADSOL * 1/1 a) 1,2, and 3 b) 1 only c) 4 and 5 d) 1,3, and 4

    d) 1,3, and 4

  • 57

    Kernicterus: * 0/1 a) decreased B1 b) increased unconjugated bilirubin c) increased conjugated bilirubin d) decreased B2

    b) increased unconjugated bilirubin

  • 58

    Why do Rh-negatiive women tend to have a positive antibody screen compared with Rh-positive women of childbearing age? * 1/1 a) They have formed active Anti-D b) They have received RhIg c) They have formed anti-K d) They have a higher rate of transfusion

    b) They have received RhIg

  • 59

    Which is the most significant agent formed in the phagolysosome for the killing of microorganisms? * 0/1 a) Proteolytic enzymes b) Hydroxyl radicals c) Hydrogen peroxide d) Superoxides

    c) Hydrogen peroxide

  • 60

    Which of the following white blood cells is capable of further differentiation in the tissues? * 0/1 a) Neutrophil b) Eosinophil c) Basophil d) Monocyte

    d) Monocyte

  • 61

    Which of the following plays an important role as an external defense mechanism? * 0/1 a) Phagocytosis b) C-reactive protein c) Lysozyme d) Complement

    c) Lysozyme

  • 62

    How much diluent needs to be added to 0.2 ml of serum to make a 1:20 dilution? * 0/1 a) 19.8 mL b) 4.0 mL c) 3.8 mL d) 10.0 m

    c) 3.8 mL

  • 63

    Which of the following statements accurately describes competitive binding assays? * 1/1 a) Excess binding sites for the analyte are provided. b) Labeled and unlabeled analyte are present in equal amounts. c) The concentration of patient analyte is inversely proportional to bound radioactive label. d) All the patient analyte is bound in the reaction.

    c) The concentration of patient analyte is inversely proportional to bound radioactive label.

  • 64

    How do heterogeneous assays differ from homogeneous assays? * 0/1 a) Heterogeneous assays require a separation step. b) Heterogeneous assays are easier to perform than homogeneous assays. c) The concentration of patient analyte is directly proportional to bound label in homogeneous assays. d) Homogeneous assays are more sensitive than heterogeneous ones.

    a) Heterogeneous assays require a separation step.

  • 65

    In a noncompetitive enzyme immunoassay, if a negative control shows the presence of color, which of the following might be a possible explanation? * 0/1 a) No reagent was added. b) Washing steps were incomplete. c) The enzyme was inactivated. d) No substrate was present.

    b) Washing steps were incomplete.

  • 66

    Which of the following techniques uses restriction enzymes, electrophoresis, and then transfer of DNA fragments onto a solid matrix, followed by probing with labeled probes? * 0/1 a) Dot-blot b) Southern blot c) Western blot d) LCR

    b) Southern blot

  • 67

    Most of the pathology associated with parasitic infections results from which of the following? * 0/1 a) Symbiotic relationships with the host b) Elaborate parasitic life cycles c) Immune response to the offending organism d) Innate defense mechanisms of the host

    c) Immune response to the offending organism

  • 68

    The chronic nature of parasitic infections is due to the host’s * 0/1 a) inability to eliminate the infective agent. b) type I hypersensitivity response to the infection. c) ability to form a granuloma around the parasite. d) tendency to form circulating immune complexes

    a) inability to eliminate the infective agent.

  • 69

    Antigen-antibody reactions are: * 0/1 a) Irreversible b) Reversible c) Lattice formation d) Cross links

    b) Reversible

  • 70

    PCR technology can be used to: * 1/1 a) Amplify small amounts of DNA. b) Isolate intact nuclear RNA. c) Digest genomic DNA into small fragments. d) Repair broken pieces of DNA.

    a) Amplify small amounts of DNA.

  • 71

    Part of the surrogate testing for HBV that is no longer required: * 0/1 a) ALT b) HBsAg c) Anti-HBc d) GGT

    a) ALT

  • 72

    What should you do to a whole blood with not adjusted anticoagulant? Underfilled blood * 1/1 a) Label as pRBC b) Label as pRBC, low volume indicated c) Label as FFP d) Discard the unit

    b) Label as pRBC, low volume indicated

  • 73

    Which of the following is proper procedure for preparation of platelets from whole blood? * 1/1 a) Light spin followed by a hard spin b) Light spin followed by two hard spins c) Two light spins d) Hard spin followed by a light spin

    a) Light spin followed by a hard spin

  • 74

    Plastic bag overwraps are recommended when thawing units of FFP in 37oC water baths because they prevent: * 0/1 a) The FFP bag from cracking when it contacts the warm water b) Water from slowly dialyzing across the bag membrane c) The entry ports from becoming contaminate with water d) The label from peeling off as the water circulates in the bath

    c) The entry ports from becoming contaminate with water

  • 75

    A 10% red cell suspension in saline is used in a compatibility test. Which of the following would most likely occur? * 0/1 a) False-positive due to antigen excess b) False-positive due to prozone c) False-negative due to prozone d) False-negative due to antigen excess

    d) False-negative due to antigen excess

  • 76

    Results of a serum sample tested against a panel of reagent red cells gives presumptive evidence of an alloantibody directed against a high incidence antigen. Further investigation to confirm the specificity should include which of the following? * 0/1 a) Serum testing against red cells from random donors b) Serum testing against red cells known to lack incidence antigens c) Serum testing against enzyme-treated autologous red cells d) Testing of an eluate prepared form the patient’s red cells

    b) Serum testing against red cells known to lack incidence antigens

  • 77

    AHG control cells: * 0/1 a) Positive control for anti-C3 reagents b) Only for IAT c) Coated only with IgG antibody d) Must be used to confirm all positive antiglobulin reactions

    c) Coated only with IgG antibody

  • 78

    .Which of the following is consistent with standard blood bank procedure governing the infusion of fresh frozen plasma, except? * 0/1 a) Only blood group-specific plasma may be administered b) Group O may be administered to recipients of all blood groups c) Group AB may be administered to AB recipients only d) Group A may be administered to both A and O recipient

    d) Group A may be administered to both A and O recipient

  • 79

    The most serious HTRs are due to which incompatibility: * 1/1 a) ABO b) Rh c) MN d) Duffy

    a) ABO

  • 80

    Most frequent transfusion-associated disease complication of blood transfusions is: * 0/1 a) CMV b) Syphilis c) Hepatitis d) AIDS

    c) Hepatitis

  • 81

    When soluble antigens diffuse in a gel that contains antibody, in which zone does optimum precipitation occur? * 0/1 a) Prozone b) Zone of equivalence c) Postzone d) Prezone

    b) Zone of equivalence

  • 82

    The following mainly transmitted through fecal/oral route: 1. HAV 2. HEV 3. HCV 4. HBV * 1/1 a) 1 and 2 b) 1 and 3 c) 1,2 and 3 d) 1,2,3 and 4

    a) 1 and 2

  • 83

    What is the transport temperature for red cells? * 0/1 a) Between 2°C and 6°C b) Between 1°C and 4°C c) Between 1°C and 6°C d) Between 2°C and 10°C

    d) Between 2°C and 10°C

  • 84

    The term used when an individual received the same 2 alleles from each parent * 1/1 a) Homozygous b) Heterozyous c) Dominant d) Recessive

    a) Homozygous

  • 85

    The law mandates that all Blood Banks should have a? * 1/1 a) Foot-operated sink b) Biosafety cabinet c) Safety plan d) Fume hoods

    c) Safety plan

  • 86

    Which is NOT nontreponemal tests? 1. FTA-ABS 2. VDRL 3. RPR 4. MHA-TP 5. RST 6. USR 7. TRUST * 0/1 a) 2 and 4 b) 2 and 3 c) 1 and 7 d) 1 and 4

    d) 1 and 4

  • 87

    The required tests for the disease transmission prevention, EXCEPT? * 1/1 a) Tuberculosis b) HIV c) Malaria d) Syphilis

    a) Tuberculosis

  • 88

    How much anticoagulant is needed for 280 mL sample? * 0/1 a) 28 mL b) 39 mL c) 63 mL d) 70 mL

    b) 39 mL

  • 89

    What is the simplest test to evaluate the cellular immune system in a patient? * 0/1 a) Skin test b)Immunoelectrophoresis c) Protein electrophoresis d) Antibody titer

    a) Skin test

  • 90

    Which blood type can produced all FOUR blood types * 1/1 a) AA and BB b) AB and BO c) AB and AB d) BB and O

    b) AB and BO

  • 91

    Component of humoral immunity * 0/1 a) Antibodies b) Saliva c) T cell d) B cell

    a) Antibodies

  • 92

    Recombinant DNA techniques: * 0/1 a) Are not used in a clinical setting b) Are useful research tools c) Are not used in blood banking d) Are useful only for research

    d) Are useful only for research

  • 93

    nti-U will not react with which of the following RBCs? * 0/1 a)M+N+S+s– b)M+N–S–s– c)M–N+S–s+ d) M+N–S+s+

    b)M+N–S–s–

  • 94

    Can you accurately interpret a patient’s group AB, D- positive result in ABO and D typing tests using monoclonal antibody reagents without additional testing? * 0/1 a) YES b) NO c) Either d) Cannot be determine

    b) NO

  • 95

    What lectin possesses the specificity for the H antigen? * 1/1 a) Iberis amara b) Dolichos biflorus c) Ulex europaeus d) Vicia graminea

    c) Ulex europaeus

  • 96

    What is the term that describes the number of cases of a disease present in a particular population at a given time? * 0/1 a) Incidence b) Prevalence c) Case occurrence d) Window period

    b) Prevalence

  • 97

    What labile coagulation factors are present in fresh frozen plasma (FFP)? 1. Factor V 2. Fibrinogen 3. Anti-hemophilic factor 4. Factor IX * 1/1 a) 1 and 2 b) 1 and 3 c) 2 and 3 d) 3 and 4

    b) 1 and 3

  • 98

    Protein A captures antibodies by binding to: * 1/1 a) Fab portion of immunoglobulin b) Fc portion of immunoglobulin c) Surface of test cells d) Surface of indicator cells

    b) Fc portion of immunoglobulin

  • 99

    How does irradiation affect the shelf-life of red blood cells? * 1/1 a) Irradiation has no effect on the shelf-life. b) The expiration date is 28 days from the date of irradiation or the original outdate, whichever is later. c) The expiration date is 28 days from the date of irradiation or the original outdate, whichever is sooner. d) The expiration date is 25 days from the date of irradiation

    c) The expiration date is 28 days from the date of irradiation or the original outdate, whichever is sooner.

  • 100

    Which patient does not need an irradiated component? * 0/1 a) Bone marrow transplant recipient b) Neonate weighing less than 1,200 g c) Adult receiving an RBC transfusion d) Adult receiving an RBC transfusion from a blood relative

    c) Adult receiving an RBC transfusion

  • other names parasitology

    other names parasitology

    Yves Laure Pimentel · 70問 · 2年前

    other names parasitology

    other names parasitology

    70問 • 2年前
    Yves Laure Pimentel

    PARASITOLOGY

    PARASITOLOGY

    Yves Laure Pimentel · 111問 · 2年前

    PARASITOLOGY

    PARASITOLOGY

    111問 • 2年前
    Yves Laure Pimentel

    HTMLBE

    HTMLBE

    Yves Laure Pimentel · 64問 · 2年前

    HTMLBE

    HTMLBE

    64問 • 2年前
    Yves Laure Pimentel

    CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

    CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

    Yves Laure Pimentel · 61問 · 2年前

    CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

    CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

    61問 • 2年前
    Yves Laure Pimentel

    HISTOPATHOLOGY

    HISTOPATHOLOGY

    Yves Laure Pimentel · 69問 · 2年前

    HISTOPATHOLOGY

    HISTOPATHOLOGY

    69問 • 2年前
    Yves Laure Pimentel

    CC-2 SPECTROPHOTOMETRY

    CC-2 SPECTROPHOTOMETRY

    Yves Laure Pimentel · 100問 · 2年前

    CC-2 SPECTROPHOTOMETRY

    CC-2 SPECTROPHOTOMETRY

    100問 • 2年前
    Yves Laure Pimentel

    CC-3 ELECTROPHORESIS

    CC-3 ELECTROPHORESIS

    Yves Laure Pimentel · 41問 · 2年前

    CC-3 ELECTROPHORESIS

    CC-3 ELECTROPHORESIS

    41問 • 2年前
    Yves Laure Pimentel

    AUBF LAB SAFETY

    AUBF LAB SAFETY

    Yves Laure Pimentel · 87問 · 2年前

    AUBF LAB SAFETY

    AUBF LAB SAFETY

    87問 • 2年前
    Yves Laure Pimentel

    CSF 1

    CSF 1

    Yves Laure Pimentel · 100問 · 2年前

    CSF 1

    CSF 1

    100問 • 2年前
    Yves Laure Pimentel

    CSF 2

    CSF 2

    Yves Laure Pimentel · 82問 · 2年前

    CSF 2

    CSF 2

    82問 • 2年前
    Yves Laure Pimentel

    SEMEN 1

    SEMEN 1

    Yves Laure Pimentel · 100問 · 2年前

    SEMEN 1

    SEMEN 1

    100問 • 2年前
    Yves Laure Pimentel

    SEMEN 2

    SEMEN 2

    Yves Laure Pimentel · 7問 · 2年前

    SEMEN 2

    SEMEN 2

    7問 • 2年前
    Yves Laure Pimentel

    SYNOVIAL FLUID 1

    SYNOVIAL FLUID 1

    Yves Laure Pimentel · 100問 · 2年前

    SYNOVIAL FLUID 1

    SYNOVIAL FLUID 1

    100問 • 2年前
    Yves Laure Pimentel

    SYNOVIAL FLUID 2

    SYNOVIAL FLUID 2

    Yves Laure Pimentel · 6問 · 2年前

    SYNOVIAL FLUID 2

    SYNOVIAL FLUID 2

    6問 • 2年前
    Yves Laure Pimentel

    SEROUS FLUID

    SEROUS FLUID

    Yves Laure Pimentel · 25問 · 2年前

    SEROUS FLUID

    SEROUS FLUID

    25問 • 2年前
    Yves Laure Pimentel

    PLEURAL FLUID

    PLEURAL FLUID

    Yves Laure Pimentel · 44問 · 2年前

    PLEURAL FLUID

    PLEURAL FLUID

    44問 • 2年前
    Yves Laure Pimentel

    PERICARDIAL FLUID

    PERICARDIAL FLUID

    Yves Laure Pimentel · 18問 · 2年前

    PERICARDIAL FLUID

    PERICARDIAL FLUID

    18問 • 2年前
    Yves Laure Pimentel

    PERITONEAL FLUID/ ASCITIC FLUID

    PERITONEAL FLUID/ ASCITIC FLUID

    Yves Laure Pimentel · 30問 · 2年前

    PERITONEAL FLUID/ ASCITIC FLUID

    PERITONEAL FLUID/ ASCITIC FLUID

    30問 • 2年前
    Yves Laure Pimentel

    AMNIOTIC FLUID

    AMNIOTIC FLUID

    Yves Laure Pimentel · 92問 · 2年前

    AMNIOTIC FLUID

    AMNIOTIC FLUID

    92問 • 2年前
    Yves Laure Pimentel

    FECALYSIS

    FECALYSIS

    Yves Laure Pimentel · 80問 · 2年前

    FECALYSIS

    FECALYSIS

    80問 • 2年前
    Yves Laure Pimentel

    OTHER BODY FLUIDS

    OTHER BODY FLUIDS

    Yves Laure Pimentel · 89問 · 2年前

    OTHER BODY FLUIDS

    OTHER BODY FLUIDS

    89問 • 2年前
    Yves Laure Pimentel

    MTLBE- SUHO NOTES

    MTLBE- SUHO NOTES

    Yves Laure Pimentel · 86問 · 2年前

    MTLBE- SUHO NOTES

    MTLBE- SUHO NOTES

    86問 • 2年前
    Yves Laure Pimentel

    MTLBE..

    MTLBE..

    Yves Laure Pimentel · 35問 · 2年前

    MTLBE..

    MTLBE..

    35問 • 2年前
    Yves Laure Pimentel

    CC- CHROMATOGRAPHY

    CC- CHROMATOGRAPHY

    Yves Laure Pimentel · 19問 · 1年前

    CC- CHROMATOGRAPHY

    CC- CHROMATOGRAPHY

    19問 • 1年前
    Yves Laure Pimentel

    CC-OSMOMETRY

    CC-OSMOMETRY

    Yves Laure Pimentel · 14問 · 1年前

    CC-OSMOMETRY

    CC-OSMOMETRY

    14問 • 1年前
    Yves Laure Pimentel

    CC-ELECTROCHEMISTRY TECHNIQUES

    CC-ELECTROCHEMISTRY TECHNIQUES

    Yves Laure Pimentel · 43問 · 1年前

    CC-ELECTROCHEMISTRY TECHNIQUES

    CC-ELECTROCHEMISTRY TECHNIQUES

    43問 • 1年前
    Yves Laure Pimentel

    CC- CARBOHYDRATES

    CC- CARBOHYDRATES

    Yves Laure Pimentel · 49問 · 2年前

    CC- CARBOHYDRATES

    CC- CARBOHYDRATES

    49問 • 2年前
    Yves Laure Pimentel

    CC- DIABETES MELLITUS

    CC- DIABETES MELLITUS

    Yves Laure Pimentel · 97問 · 2年前

    CC- DIABETES MELLITUS

    CC- DIABETES MELLITUS

    97問 • 2年前
    Yves Laure Pimentel

    MAJOR LIPOPROTEINS

    MAJOR LIPOPROTEINS

    Yves Laure Pimentel · 57問 · 2年前

    MAJOR LIPOPROTEINS

    MAJOR LIPOPROTEINS

    57問 • 2年前
    Yves Laure Pimentel

    MINOR LIPOPROTEINS

    MINOR LIPOPROTEINS

    Yves Laure Pimentel · 63問 · 2年前

    MINOR LIPOPROTEINS

    MINOR LIPOPROTEINS

    63問 • 2年前
    Yves Laure Pimentel

    PROTEINS

    PROTEINS

    Yves Laure Pimentel · 37問 · 2年前

    PROTEINS

    PROTEINS

    37問 • 2年前
    Yves Laure Pimentel

    PLASMA PROTEINS 1

    PLASMA PROTEINS 1

    Yves Laure Pimentel · 91問 · 2年前

    PLASMA PROTEINS 1

    PLASMA PROTEINS 1

    91問 • 2年前
    Yves Laure Pimentel

    PLASMA PROTEINS 2 (ALPHA 2 REGION)

    PLASMA PROTEINS 2 (ALPHA 2 REGION)

    Yves Laure Pimentel · 98問 · 2年前

    PLASMA PROTEINS 2 (ALPHA 2 REGION)

    PLASMA PROTEINS 2 (ALPHA 2 REGION)

    98問 • 2年前
    Yves Laure Pimentel

    MISCELLANEOUS PROTEINS

    MISCELLANEOUS PROTEINS

    Yves Laure Pimentel · 61問 · 2年前

    MISCELLANEOUS PROTEINS

    MISCELLANEOUS PROTEINS

    61問 • 2年前
    Yves Laure Pimentel

    Liver Function Test 1

    Liver Function Test 1

    Yves Laure Pimentel · 100問 · 2年前

    Liver Function Test 1

    Liver Function Test 1

    100問 • 2年前
    Yves Laure Pimentel

    Liver Function Test 2

    Liver Function Test 2

    Yves Laure Pimentel · 96問 · 2年前

    Liver Function Test 2

    Liver Function Test 2

    96問 • 2年前
    Yves Laure Pimentel

    TUMOR MARKERS

    TUMOR MARKERS

    Yves Laure Pimentel · 33問 · 2年前

    TUMOR MARKERS

    TUMOR MARKERS

    33問 • 2年前
    Yves Laure Pimentel

    KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

    KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

    Yves Laure Pimentel · 41問 · 2年前

    KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

    KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

    41問 • 2年前
    Yves Laure Pimentel

    GLYCOGEN STORAGE DISEASES

    GLYCOGEN STORAGE DISEASES

    Yves Laure Pimentel · 17問 · 2年前

    GLYCOGEN STORAGE DISEASES

    GLYCOGEN STORAGE DISEASES

    17問 • 2年前
    Yves Laure Pimentel

    LIPID STORAGE DISEASES

    LIPID STORAGE DISEASES

    Yves Laure Pimentel · 14問 · 2年前

    LIPID STORAGE DISEASES

    LIPID STORAGE DISEASES

    14問 • 2年前
    Yves Laure Pimentel

    PROTEINS

    PROTEINS

    Yves Laure Pimentel · 71問 · 2年前

    PROTEINS

    PROTEINS

    71問 • 2年前
    Yves Laure Pimentel

    QUICK FIRE- ELECTRODES

    QUICK FIRE- ELECTRODES

    Yves Laure Pimentel · 7問 · 2年前

    QUICK FIRE- ELECTRODES

    QUICK FIRE- ELECTRODES

    7問 • 2年前
    Yves Laure Pimentel

    ELECTROLYTES

    ELECTROLYTES

    Yves Laure Pimentel · 10問 · 2年前

    ELECTROLYTES

    ELECTROLYTES

    10問 • 2年前
    Yves Laure Pimentel

    DRUGS

    DRUGS

    Yves Laure Pimentel · 27問 · 2年前

    DRUGS

    DRUGS

    27問 • 2年前
    Yves Laure Pimentel

    TOXIC AGENTS:

    TOXIC AGENTS:

    Yves Laure Pimentel · 12問 · 2年前

    TOXIC AGENTS:

    TOXIC AGENTS:

    12問 • 2年前
    Yves Laure Pimentel

    HEMATOLOGY 1 (HEMATOPOIESIS 1)

    HEMATOLOGY 1 (HEMATOPOIESIS 1)

    Yves Laure Pimentel · 100問 · 2年前

    HEMATOLOGY 1 (HEMATOPOIESIS 1)

    HEMATOLOGY 1 (HEMATOPOIESIS 1)

    100問 • 2年前
    Yves Laure Pimentel

    HEMATOLOGY (HEMATOPOIESIS 2)

    HEMATOLOGY (HEMATOPOIESIS 2)

    Yves Laure Pimentel · 29問 · 2年前

    HEMATOLOGY (HEMATOPOIESIS 2)

    HEMATOLOGY (HEMATOPOIESIS 2)

    29問 • 2年前
    Yves Laure Pimentel

    hema diseases

    hema diseases

    Yves Laure Pimentel · 25問 · 2年前

    hema diseases

    hema diseases

    25問 • 2年前
    Yves Laure Pimentel

    AML

    AML

    Yves Laure Pimentel · 43問 · 2年前

    AML

    AML

    43問 • 2年前
    Yves Laure Pimentel

    GLOBIN SYNTHESIS

    GLOBIN SYNTHESIS

    Yves Laure Pimentel · 71問 · 2年前

    GLOBIN SYNTHESIS

    GLOBIN SYNTHESIS

    71問 • 2年前
    Yves Laure Pimentel

    HEMATOLOGY REFERENCE RANGES

    HEMATOLOGY REFERENCE RANGES

    Yves Laure Pimentel · 31問 · 2年前

    HEMATOLOGY REFERENCE RANGES

    HEMATOLOGY REFERENCE RANGES

    31問 • 2年前
    Yves Laure Pimentel

    DISORDERS OF PRIMARY HEMOSTASIS

    DISORDERS OF PRIMARY HEMOSTASIS

    Yves Laure Pimentel · 34問 · 2年前

    DISORDERS OF PRIMARY HEMOSTASIS

    DISORDERS OF PRIMARY HEMOSTASIS

    34問 • 2年前
    Yves Laure Pimentel

    PLATELET DISORDERS

    PLATELET DISORDERS

    Yves Laure Pimentel · 37問 · 2年前

    PLATELET DISORDERS

    PLATELET DISORDERS

    37問 • 2年前
    Yves Laure Pimentel

    CHARACTERISTICS OF CLOTTING FACTORS

    CHARACTERISTICS OF CLOTTING FACTORS

    Yves Laure Pimentel · 100問 · 2年前

    CHARACTERISTICS OF CLOTTING FACTORS

    CHARACTERISTICS OF CLOTTING FACTORS

    100問 • 2年前
    Yves Laure Pimentel

    4. CLASSIFICATION OF MACROPHAGE

    4. CLASSIFICATION OF MACROPHAGE

    Yves Laure Pimentel · 12問 · 2年前

    4. CLASSIFICATION OF MACROPHAGE

    4. CLASSIFICATION OF MACROPHAGE

    12問 • 2年前
    Yves Laure Pimentel

    3. NATURAL OR INNATE IMMUNITY

    3. NATURAL OR INNATE IMMUNITY

    Yves Laure Pimentel · 39問 · 2年前

    3. NATURAL OR INNATE IMMUNITY

    3. NATURAL OR INNATE IMMUNITY

    39問 • 2年前
    Yves Laure Pimentel

    5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

    5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

    Yves Laure Pimentel · 55問 · 2年前

    5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

    5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

    55問 • 2年前
    Yves Laure Pimentel

    6. PHAGOCYTOSIS Chemotaxis

    6. PHAGOCYTOSIS Chemotaxis

    Yves Laure Pimentel · 37問 · 2年前

    6. PHAGOCYTOSIS Chemotaxis

    6. PHAGOCYTOSIS Chemotaxis

    37問 • 2年前
    Yves Laure Pimentel

    8. NATURE OF ANTIGEN

    8. NATURE OF ANTIGEN

    Yves Laure Pimentel · 44問 · 2年前

    8. NATURE OF ANTIGEN

    8. NATURE OF ANTIGEN

    44問 • 2年前
    Yves Laure Pimentel

    9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

    9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

    Yves Laure Pimentel · 50問 · 2年前

    9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

    9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

    50問 • 2年前
    Yves Laure Pimentel

    1. HISTORY

    1. HISTORY

    Yves Laure Pimentel · 69問 · 2年前

    1. HISTORY

    1. HISTORY

    69問 • 2年前
    Yves Laure Pimentel

    2. TYPES OF IMMUNITY

    2. TYPES OF IMMUNITY

    Yves Laure Pimentel · 38問 · 2年前

    2. TYPES OF IMMUNITY

    2. TYPES OF IMMUNITY

    38問 • 2年前
    Yves Laure Pimentel

    7. PHAGOCYTOSIS Engulfment and Digestion

    7. PHAGOCYTOSIS Engulfment and Digestion

    Yves Laure Pimentel · 21問 · 2年前

    7. PHAGOCYTOSIS Engulfment and Digestion

    7. PHAGOCYTOSIS Engulfment and Digestion

    21問 • 2年前
    Yves Laure Pimentel

    8. PHAGOCYTOSIS EXOCYTOSIS

    8. PHAGOCYTOSIS EXOCYTOSIS

    Yves Laure Pimentel · 15問 · 2年前

    8. PHAGOCYTOSIS EXOCYTOSIS

    8. PHAGOCYTOSIS EXOCYTOSIS

    15問 • 2年前
    Yves Laure Pimentel

    10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

    10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

    Yves Laure Pimentel · 32問 · 2年前

    10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

    10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

    32問 • 2年前
    Yves Laure Pimentel

    11. TRANSPLANTATION IMMUNOLOGY

    11. TRANSPLANTATION IMMUNOLOGY

    Yves Laure Pimentel · 30問 · 2年前

    11. TRANSPLANTATION IMMUNOLOGY

    11. TRANSPLANTATION IMMUNOLOGY

    30問 • 2年前
    Yves Laure Pimentel

    2. LYMPHOID ORGANS

    2. LYMPHOID ORGANS

    Yves Laure Pimentel · 38問 · 2年前

    2. LYMPHOID ORGANS

    2. LYMPHOID ORGANS

    38問 • 2年前
    Yves Laure Pimentel

    3. CLUSTER OF DIFFERENTIATION

    3. CLUSTER OF DIFFERENTIATION

    Yves Laure Pimentel · 48問 · 2年前

    3. CLUSTER OF DIFFERENTIATION

    3. CLUSTER OF DIFFERENTIATION

    48問 • 2年前
    Yves Laure Pimentel

    4. T-CELL DIFFERENTIATION

    4. T-CELL DIFFERENTIATION

    Yves Laure Pimentel · 35問 · 2年前

    4. T-CELL DIFFERENTIATION

    4. T-CELL DIFFERENTIATION

    35問 • 2年前
    Yves Laure Pimentel

    5. T CELL IMMUNODEFICIENCIES

    5. T CELL IMMUNODEFICIENCIES

    Yves Laure Pimentel · 18問 · 2年前

    5. T CELL IMMUNODEFICIENCIES

    5. T CELL IMMUNODEFICIENCIES

    18問 • 2年前
    Yves Laure Pimentel

    6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

    6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

    Yves Laure Pimentel · 44問 · 2年前

    6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

    6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

    44問 • 2年前
    Yves Laure Pimentel

    7. B CELL IMMUNODEFICIENCIES

    7. B CELL IMMUNODEFICIENCIES

    Yves Laure Pimentel · 23問 · 2年前

    7. B CELL IMMUNODEFICIENCIES

    7. B CELL IMMUNODEFICIENCIES

    23問 • 2年前
    Yves Laure Pimentel

    8. COMBINED T CELL AND B CELL DEFICIENCIES

    8. COMBINED T CELL AND B CELL DEFICIENCIES

    Yves Laure Pimentel · 34問 · 2年前

    8. COMBINED T CELL AND B CELL DEFICIENCIES

    8. COMBINED T CELL AND B CELL DEFICIENCIES

    34問 • 2年前
    Yves Laure Pimentel

    9. COMPARISON OF T AND B CELLS

    9. COMPARISON OF T AND B CELLS

    Yves Laure Pimentel · 12問 · 2年前

    9. COMPARISON OF T AND B CELLS

    9. COMPARISON OF T AND B CELLS

    12問 • 2年前
    Yves Laure Pimentel

    10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

    10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

    Yves Laure Pimentel · 16問 · 2年前

    10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

    10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

    16問 • 2年前
    Yves Laure Pimentel

    11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

    11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

    Yves Laure Pimentel · 15問 · 2年前

    11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

    11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

    15問 • 2年前
    Yves Laure Pimentel

    12. ANTIBODY

    12. ANTIBODY

    Yves Laure Pimentel · 79問 · 2年前

    12. ANTIBODY

    12. ANTIBODY

    79問 • 2年前
    Yves Laure Pimentel

    13. TYPES OF ANTIBODIES

    13. TYPES OF ANTIBODIES

    Yves Laure Pimentel · 97問 · 2年前

    13. TYPES OF ANTIBODIES

    13. TYPES OF ANTIBODIES

    97問 • 2年前
    Yves Laure Pimentel

    14. MONOCLONAL ANTIBODIES

    14. MONOCLONAL ANTIBODIES

    Yves Laure Pimentel · 11問 · 2年前

    14. MONOCLONAL ANTIBODIES

    14. MONOCLONAL ANTIBODIES

    11問 • 2年前
    Yves Laure Pimentel

    1. INTERLEUKINS

    1. INTERLEUKINS

    Yves Laure Pimentel · 23問 · 2年前

    1. INTERLEUKINS

    1. INTERLEUKINS

    23問 • 2年前
    Yves Laure Pimentel

    2. INTERFERONS

    2. INTERFERONS

    Yves Laure Pimentel · 28問 · 2年前

    2. INTERFERONS

    2. INTERFERONS

    28問 • 2年前
    Yves Laure Pimentel

    3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

    3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

    Yves Laure Pimentel · 8問 · 2年前

    3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

    3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

    8問 • 2年前
    Yves Laure Pimentel

    4. COMPLEMENT SYSTEM

    4. COMPLEMENT SYSTEM

    Yves Laure Pimentel · 19問 · 2年前

    4. COMPLEMENT SYSTEM

    4. COMPLEMENT SYSTEM

    19問 • 2年前
    Yves Laure Pimentel

    15. COMPLEMENT SYSTEM

    15. COMPLEMENT SYSTEM

    Yves Laure Pimentel · 76問 · 2年前

    15. COMPLEMENT SYSTEM

    15. COMPLEMENT SYSTEM

    76問 • 2年前
    Yves Laure Pimentel

    16. SYSTEM CONTROLS/COMPLEMENT REGULATION

    16. SYSTEM CONTROLS/COMPLEMENT REGULATION

    Yves Laure Pimentel · 21問 · 2年前

    16. SYSTEM CONTROLS/COMPLEMENT REGULATION

    16. SYSTEM CONTROLS/COMPLEMENT REGULATION

    21問 • 2年前
    Yves Laure Pimentel

    17. COMPLEMENT AND DISEASE STATES

    17. COMPLEMENT AND DISEASE STATES

    Yves Laure Pimentel · 29問 · 2年前

    17. COMPLEMENT AND DISEASE STATES

    17. COMPLEMENT AND DISEASE STATES

    29問 • 2年前
    Yves Laure Pimentel

    18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

    18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

    Yves Laure Pimentel · 19問 · 2年前

    18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

    18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

    19問 • 2年前
    Yves Laure Pimentel

    19. CYTOKINES

    19. CYTOKINES

    Yves Laure Pimentel · 22問 · 2年前

    19. CYTOKINES

    19. CYTOKINES

    22問 • 2年前
    Yves Laure Pimentel

    20. INTERLEUKINS

    20. INTERLEUKINS

    Yves Laure Pimentel · 24問 · 2年前

    20. INTERLEUKINS

    20. INTERLEUKINS

    24問 • 2年前
    Yves Laure Pimentel

    21. INTERFERONS, TNF, TGF, CHEMOKINE

    21. INTERFERONS, TNF, TGF, CHEMOKINE

    Yves Laure Pimentel · 21問 · 2年前

    21. INTERFERONS, TNF, TGF, CHEMOKINE

    21. INTERFERONS, TNF, TGF, CHEMOKINE

    21問 • 2年前
    Yves Laure Pimentel

    1. SERO

    1. SERO

    Yves Laure Pimentel · 54問 · 2年前

    1. SERO

    1. SERO

    54問 • 2年前
    Yves Laure Pimentel

    2. PRECIPITATION

    2. PRECIPITATION

    Yves Laure Pimentel · 38問 · 2年前

    2. PRECIPITATION

    2. PRECIPITATION

    38問 • 2年前
    Yves Laure Pimentel

    3. PASSIVE IMMUNODIFFUSION

    3. PASSIVE IMMUNODIFFUSION

    Yves Laure Pimentel · 17問 · 2年前

    3. PASSIVE IMMUNODIFFUSION

    3. PASSIVE IMMUNODIFFUSION

    17問 • 2年前
    Yves Laure Pimentel

    4. OUCHTERLONY

    4. OUCHTERLONY

    Yves Laure Pimentel · 15問 · 2年前

    4. OUCHTERLONY

    4. OUCHTERLONY

    15問 • 2年前
    Yves Laure Pimentel

    5. ELECTROPHORETIC TECHNIQUE

    5. ELECTROPHORETIC TECHNIQUE

    Yves Laure Pimentel · 9問 · 2年前

    5. ELECTROPHORETIC TECHNIQUE

    5. ELECTROPHORETIC TECHNIQUE

    9問 • 2年前
    Yves Laure Pimentel

    6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

    6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

    Yves Laure Pimentel · 11問 · 2年前

    6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

    6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

    11問 • 2年前
    Yves Laure Pimentel

    7. IMMUNOFIXATION ELECTROPHORESIS

    7. IMMUNOFIXATION ELECTROPHORESIS

    Yves Laure Pimentel · 29問 · 2年前

    7. IMMUNOFIXATION ELECTROPHORESIS

    7. IMMUNOFIXATION ELECTROPHORESIS

    29問 • 2年前
    Yves Laure Pimentel

    問題一覧

  • 1

    Blood films for malaria * 0/1 A. Thin film should be fixed with methanol B. Thick film should be fixed with methanol C. Neither A or B D. Both a and b

    A. Thin film should be fixed with methanol

  • 2

    A patient showed positive results with screening cells and 4 donor units. The patient autocontrol was negative. What is the most likely antibody? * 0/1 A. Anti-H B. Anti-S C. Anti-Kpa D. Anti-k

    D. Anti-k

  • 3

    HDFN is nearly always limited to A or B infants of group ___ mothers * 0/1 A. A B. B C. O D. AB

    C. O

  • 4

    Most common cause of HDFN * 0/1 A. Rh Antibody B. ABO antibody C. Duffy Antibody D. Kell Antibody

    B. ABO antibody

  • 5

    Most lethal cause of HDFN * 1/1 A. Rh Antibody B. ABO antibody C. Duffy Antibody D. Kell Antibody

    A. Rh Antibody

  • 6

    What minor blood group has a complement? * 0/1 A. Chido-rodgers B. Knops C. Vel D. AOTA

    A. Chido-rodgers

  • 7

    What protein who is also an APR needed for coagulation of blood? * 0/1 A. Thrombin B. Fibrinogen C. Ceruloplasmin D. Haptoglobin

    B. Fibrinogen

  • 8

    Your mother is a breast cancer patient, what tumor marker should be used? * 1/1 A. CEA B. CYFRA C. CA 153 D. CA 199

    C. CA 153

  • 9

    How many diluent is needed if you have 0.2 ml of solute with a 1:20 dilution? * 0/1 A. 19.8 B. 3.8 C. 4 D. 1.8

    B. 3.8

  • 10

    What IgG subclass that is the most abundant? * 1/1 A. IgG1 B. IgG2 C. IgG3 D. IgG4

    A. IgG1

  • 11

    Cancer remission * 1/1 A. Accept B. Retest C. Defer D. Take history

    C. Defer

  • 12

    Type of Anti D except * 1/1 a. IgG b. IgM c. IgA d. IgE

    d. IgE

  • 13

    It is the most common parasitic complication of transfusion * 0/1 a. babesiosis b. malaria c. chaga d. toxoplasmosis

    b. malaria

  • 14

    P1 is considered as * 0/1 a. IgG b. IgM c. IgA d. IgE

    b. IgM

  • 15

    All of the following is required of HIV testing, except * 1/1 a. TB px b. all infants c. px w/ std d high risk population

    b. all infants

  • 16

    What should be done if you observe the stop in the flow of blood during blood donation * 1/1 A. Reposition the needle B. Draw 2nd sample C. Stop the donation D. Squeeze the line

    A. Reposition the needle

  • 17

    From the following, identify a specific component of the adaptive immune system that is formed in response to antigenic stimulation: * 0/1 a) Lysozyme b) Complement c) Commensal organisms d) Immunoglobulin

    d) Immunoglobulin

  • 18

    Which cluster of differentiation (CD) marker appears during the first stage of T-cell development and remains present as an identifying marker for T cells? * 1/1 a) CD1 b) CD2 c) CD3 d) CD4 or CD8

    b) CD2

  • 19

    All of the following are immunologic functions of complement except: * 0/1 a) Induction of an antiviral state b) Opsonization c) Chemotaxis d) Anaphylatoxin formation

    a) Induction of an antiviral state

  • 20

    Which serum antibody response usually characterizes the primary (early) stage of syphilis? * 1/1 a) Antibodies against syphilis are undetectable b) Detected 1–3 weeks after appearance of the primary chancre c) Detected in 50% of cases before the primary chancre disappears d) Detected within 2 weeks after infection

    b) Detected 1–3 weeks after appearance of the primary chancre

  • 21

    Which tests are considered screening tests for HIV? * 1/1 a) ELISA, 4th generation, and rapid antibody tests b) Immunofluorescence, Western blot, radioimmuno-precipitation assay c) Culture, antigen capture assay, DNA amplification d) Reverse transcriptase and messenger RNA (mRNA) ass

    a) ELISA, 4th generation, and rapid antibody tests

  • 22

    Interpret the following results for HIV infection. ELISA: positive; Repeat ELISA: negative; Western blot: no bands * 1/1 a) Positive for HIV b) Negative for HIV c) Indeterminate d) Further testing needed

    b) Negative for HIV

  • 23

    Which CD4:CD8 ratio is most likely in a patient with AIDS? * 1/1 a) 2:1 b) 3:1 c) 2:3 d) 1:2

    d) 1:2

  • 24

    What should be done if all forward and reverse ABO results as well as the autocontrol are positive? * 1/1 a) Wash the cells with warm saline, autoadsorb the serum at 4oC b) Retype the sample using a different lot number of reagents c) Use polyclonal typing reagents d) Report the sample as group AB

    a) Wash the cells with warm saline, autoadsorb the serum at 4oC

  • 25

    The k (Cellano) antigen is a high-frequency antigen and is found on most red cells. How often would one expect to find the corresponding antibody? * 1/1 a) Often b) Rarely c) Always d) Never

    b) Rarely

  • 26

    Which of the following is not a requirement for the electronic crossmatch? * 1/1 a) The computer system contains logic to prevent assignment and release of ABO incompatible blood b) There are concordant results of at least two determinations of the recipient’s ABO type on record, one of which is from the current sample c) Critical elements of the system have been validated on site d) There are concordant results of at least one determination of the recipient’s ABO type on file

    d) There are concordant results of at least one determination of the recipient’s ABO type on file

  • 27

    What ABO types may donate to any other ABO type? * 1/1 a) O- b) A-, O- c) A- d) A-,B-,AB-,O-

    a) O-

  • 28

    A major crossmatch and screening cells are 2+ at IS, 1+ at 37°C, and negative at the IAT phase. Identify the most likely problem. * 1/1 a) Combination of antibodies b) Cold alloantibody c) Rouleaux d) Test error

    b) Cold alloantibody

  • 29

    All of the following are reasons for performing an adsorption, except: * 0/1 a) Separation of mixtures of antibodies b) Removal of interfering substances c) Confirmation of weak antigens on red cells d) Identification of antibodies causing a positive DAT

    d) Identification of antibodies causing a positive DAT

  • 30

    When may an immediate spin crossmatch be performed? * 0/1 a) When a patient is being massively transfused b) When there is no history of antibodies and the current antibody screen is negative c) When blood is being emergency released d) When a patient has not been transfused in the past 3 months

    b) When there is no history of antibodies and the current antibody screen is negative

  • 31

    Which of the following vaccinations carries no deferral period? * 1/1 a) Rubella b) Varicella zoster c) HPV d) Small pox

    c) HPV

  • 32

    What should be done when a woman who is 24 weeks pregnant has a positive antibody screen? * 0/1 a) Perform an antibody identification panel; titer if necessary b) No need to do anything until 30 weeks gestation c) Administer Rh immune globulin (RhIg) d) Adsorb the antibody onto antigen-positive cells

    a) Perform an antibody identification panel; titer if necessary

  • 33

    What is the latest method used in detecting HIV infection in its early acute phase? * 1/1 a) ELISA b) Southern Blot c) Western blot d) Nucleic acid amplification testing

    d) Nucleic acid amplification testing

  • 34

    Who is the best candidate for a predeposit autologous donation? * 1/1 a) A 45-year-old man who is having elective surgery in 2 weeks; he has alloanti-k b) A 23-year-old female leukemia patient with a hemoglobin of 10 g/dL c) A 12-year-old boy who has hemophilia d) A 53-year-old woman who has septicemia

    a) A 45-year-old man who is having elective surgery in 2 weeks; he has alloanti-k

  • 35

    ANA tests are performed to help diagnose which condition: * 1/1 a) SLE b) Rheumatoid arthritis c) Leukemia d) Hemolytic anemia

    a) SLE

  • 36

    To make a presumptive diagnosis of RA, which of the following qualitative methods is MOST sensitive * 0/1 a) Latex agglutination b) Immunoelectrophoresis c) RID d) ELISA

    a) Latex agglutination

  • 37

    In chronic active hepatitis, high titers of which of the following antibodies are seen? * 1/1 a) Anti-smooth muscle b) Antimitochondrial c) Anti-DNA d) Anti-parietal cell

    a) Anti-smooth muscle

  • 38

    Anti-glomerular basement membrane antibody is MOST often associated with this condition: * 1/1 a) Goodpasture disease b) SLE c) Celiac disease d) Chronic active hepatitis

    a) Goodpasture disease

  • 39

    Flocculation tests for syphilis detect the presence of * 1/1 a) Reagin b) Antigen c) Hemolysin d) Forssman antigen

    a) Reagin

  • 40

    Which of the following is a treponemal test? * 1/1 a) RST b) RPR c) FTA-ABS d) VDRL

    c) FTA-ABS

  • 41

    The key structural difference that distinguishes immunoglobulin subclasses: * 0/1 a) Stereometry of the hypervariable region b) Number of domains c) Sequence of the constant regions d) Number of disulfide bridges

    c) Sequence of the constant regions

  • 42

    Antibody idiotype is dictated by the * 0/1 a) Constant region of heavy chain b) Constant region of light chain c) Constant regions of heavy and light chains d) Variable regions of heavy and light chains

    d) Variable regions of heavy and light chains

  • 43

    Immunoglobulin that is most efficient at crossing the placenta: * 1/1 a) IgG b) IgA c) IgM d) IgD

    a) IgG

  • 44

    Which is most likely to activate the alternative pathway * 0/1 a) Lipopolysaccharide b) Glycoproteins c) Haptens d) IgG complexed with antige

    a) Lipopolysaccharide

  • 45

    T lymphocytes are incapable of functioning as: * 0/1 a) Cytotoxic cells b) Helper cells c) Phagocytic cells d) Regulatory cells

    c) Phagocytic cells

  • 46

    Which test is used to evaluate the cellular immune system in a patient? * 0/1 a) Skin test for commonly encountered antigens b) Determination of isohemagglutinin titer c) Immunoelectrophoresis of serum d) Measurement of anti-HBsAg after immunization

    a) Skin test for commonly encountered antigens

  • 47

    Tumor markers found in the circulation are most frequently measured by: * 1/1 a) Immunoassays b) TLC c) HPLC d) Colorimetry

    a) Immunoassays

  • 48

    Antigen receptors on T lymphocytes bind HLA class II molecules with the help of which accessory molecule? * 0/1 a) CD2 b) CD3 c) CD4 d) CD8

    c) CD4

  • 49

    Bone marrow transplant donors and their recipients must be matched for which antigen systems * 0/1 a) ABO & Rh b) HLA c) CD4/CD8 d) P

    b) HLA

  • 50

    Which antibody characteristically gives a refractile mixed-field appearance? * 1/1 a) Anti-K b) Anti-Dia c) Anti-Sda d) Anti-s

    c) Anti-Sda

  • 51

    What does a minor crossmatch consist of? * 1/1 a) Recipient plasma and recipient red cells b) Recipient plasma and donor red cells c) Recipient red cells and donor plasma d) Donor plasma and donor red cells

    c) Recipient red cells and donor plasma

  • 52

    Most common Di phenotype is often associated with what ancestry: * 0/1 a) Asian b) African c) European d) Mongolian

    d) Mongolian

  • 53

    A 47-year old man with a history of cancer wants to donate blood. What would the MTOD do? * 0/1 a) Defer b) Defer for 1 year c) Defer for 3 years d) Accept

    a) Defer

  • 54

    Symptoms of dyspnea, cough, hypoxemia, and pulmonary edema within 6 hours of transfusion: * 0/1 a) Anaphylactic b) Hemolytic c) TRALI d) TACO

    c) TRALI

  • 55

    Which is NOT a correct match of blood component and its temperature? * 0/1 a) Frozen RBCs: -18°C b) Platelets: 20-24°C c) FFP: -65 d) Cryoprecipitate: -18°C

    a) Frozen RBCs: -18°C

  • 56

    The anticoagulant/s with the shelf life of 21 days: 1. CPD 2. CPDA-1 3. CP2D 4. ACD 5. ADSOL * 1/1 a) 1,2, and 3 b) 1 only c) 4 and 5 d) 1,3, and 4

    d) 1,3, and 4

  • 57

    Kernicterus: * 0/1 a) decreased B1 b) increased unconjugated bilirubin c) increased conjugated bilirubin d) decreased B2

    b) increased unconjugated bilirubin

  • 58

    Why do Rh-negatiive women tend to have a positive antibody screen compared with Rh-positive women of childbearing age? * 1/1 a) They have formed active Anti-D b) They have received RhIg c) They have formed anti-K d) They have a higher rate of transfusion

    b) They have received RhIg

  • 59

    Which is the most significant agent formed in the phagolysosome for the killing of microorganisms? * 0/1 a) Proteolytic enzymes b) Hydroxyl radicals c) Hydrogen peroxide d) Superoxides

    c) Hydrogen peroxide

  • 60

    Which of the following white blood cells is capable of further differentiation in the tissues? * 0/1 a) Neutrophil b) Eosinophil c) Basophil d) Monocyte

    d) Monocyte

  • 61

    Which of the following plays an important role as an external defense mechanism? * 0/1 a) Phagocytosis b) C-reactive protein c) Lysozyme d) Complement

    c) Lysozyme

  • 62

    How much diluent needs to be added to 0.2 ml of serum to make a 1:20 dilution? * 0/1 a) 19.8 mL b) 4.0 mL c) 3.8 mL d) 10.0 m

    c) 3.8 mL

  • 63

    Which of the following statements accurately describes competitive binding assays? * 1/1 a) Excess binding sites for the analyte are provided. b) Labeled and unlabeled analyte are present in equal amounts. c) The concentration of patient analyte is inversely proportional to bound radioactive label. d) All the patient analyte is bound in the reaction.

    c) The concentration of patient analyte is inversely proportional to bound radioactive label.

  • 64

    How do heterogeneous assays differ from homogeneous assays? * 0/1 a) Heterogeneous assays require a separation step. b) Heterogeneous assays are easier to perform than homogeneous assays. c) The concentration of patient analyte is directly proportional to bound label in homogeneous assays. d) Homogeneous assays are more sensitive than heterogeneous ones.

    a) Heterogeneous assays require a separation step.

  • 65

    In a noncompetitive enzyme immunoassay, if a negative control shows the presence of color, which of the following might be a possible explanation? * 0/1 a) No reagent was added. b) Washing steps were incomplete. c) The enzyme was inactivated. d) No substrate was present.

    b) Washing steps were incomplete.

  • 66

    Which of the following techniques uses restriction enzymes, electrophoresis, and then transfer of DNA fragments onto a solid matrix, followed by probing with labeled probes? * 0/1 a) Dot-blot b) Southern blot c) Western blot d) LCR

    b) Southern blot

  • 67

    Most of the pathology associated with parasitic infections results from which of the following? * 0/1 a) Symbiotic relationships with the host b) Elaborate parasitic life cycles c) Immune response to the offending organism d) Innate defense mechanisms of the host

    c) Immune response to the offending organism

  • 68

    The chronic nature of parasitic infections is due to the host’s * 0/1 a) inability to eliminate the infective agent. b) type I hypersensitivity response to the infection. c) ability to form a granuloma around the parasite. d) tendency to form circulating immune complexes

    a) inability to eliminate the infective agent.

  • 69

    Antigen-antibody reactions are: * 0/1 a) Irreversible b) Reversible c) Lattice formation d) Cross links

    b) Reversible

  • 70

    PCR technology can be used to: * 1/1 a) Amplify small amounts of DNA. b) Isolate intact nuclear RNA. c) Digest genomic DNA into small fragments. d) Repair broken pieces of DNA.

    a) Amplify small amounts of DNA.

  • 71

    Part of the surrogate testing for HBV that is no longer required: * 0/1 a) ALT b) HBsAg c) Anti-HBc d) GGT

    a) ALT

  • 72

    What should you do to a whole blood with not adjusted anticoagulant? Underfilled blood * 1/1 a) Label as pRBC b) Label as pRBC, low volume indicated c) Label as FFP d) Discard the unit

    b) Label as pRBC, low volume indicated

  • 73

    Which of the following is proper procedure for preparation of platelets from whole blood? * 1/1 a) Light spin followed by a hard spin b) Light spin followed by two hard spins c) Two light spins d) Hard spin followed by a light spin

    a) Light spin followed by a hard spin

  • 74

    Plastic bag overwraps are recommended when thawing units of FFP in 37oC water baths because they prevent: * 0/1 a) The FFP bag from cracking when it contacts the warm water b) Water from slowly dialyzing across the bag membrane c) The entry ports from becoming contaminate with water d) The label from peeling off as the water circulates in the bath

    c) The entry ports from becoming contaminate with water

  • 75

    A 10% red cell suspension in saline is used in a compatibility test. Which of the following would most likely occur? * 0/1 a) False-positive due to antigen excess b) False-positive due to prozone c) False-negative due to prozone d) False-negative due to antigen excess

    d) False-negative due to antigen excess

  • 76

    Results of a serum sample tested against a panel of reagent red cells gives presumptive evidence of an alloantibody directed against a high incidence antigen. Further investigation to confirm the specificity should include which of the following? * 0/1 a) Serum testing against red cells from random donors b) Serum testing against red cells known to lack incidence antigens c) Serum testing against enzyme-treated autologous red cells d) Testing of an eluate prepared form the patient’s red cells

    b) Serum testing against red cells known to lack incidence antigens

  • 77

    AHG control cells: * 0/1 a) Positive control for anti-C3 reagents b) Only for IAT c) Coated only with IgG antibody d) Must be used to confirm all positive antiglobulin reactions

    c) Coated only with IgG antibody

  • 78

    .Which of the following is consistent with standard blood bank procedure governing the infusion of fresh frozen plasma, except? * 0/1 a) Only blood group-specific plasma may be administered b) Group O may be administered to recipients of all blood groups c) Group AB may be administered to AB recipients only d) Group A may be administered to both A and O recipient

    d) Group A may be administered to both A and O recipient

  • 79

    The most serious HTRs are due to which incompatibility: * 1/1 a) ABO b) Rh c) MN d) Duffy

    a) ABO

  • 80

    Most frequent transfusion-associated disease complication of blood transfusions is: * 0/1 a) CMV b) Syphilis c) Hepatitis d) AIDS

    c) Hepatitis

  • 81

    When soluble antigens diffuse in a gel that contains antibody, in which zone does optimum precipitation occur? * 0/1 a) Prozone b) Zone of equivalence c) Postzone d) Prezone

    b) Zone of equivalence

  • 82

    The following mainly transmitted through fecal/oral route: 1. HAV 2. HEV 3. HCV 4. HBV * 1/1 a) 1 and 2 b) 1 and 3 c) 1,2 and 3 d) 1,2,3 and 4

    a) 1 and 2

  • 83

    What is the transport temperature for red cells? * 0/1 a) Between 2°C and 6°C b) Between 1°C and 4°C c) Between 1°C and 6°C d) Between 2°C and 10°C

    d) Between 2°C and 10°C

  • 84

    The term used when an individual received the same 2 alleles from each parent * 1/1 a) Homozygous b) Heterozyous c) Dominant d) Recessive

    a) Homozygous

  • 85

    The law mandates that all Blood Banks should have a? * 1/1 a) Foot-operated sink b) Biosafety cabinet c) Safety plan d) Fume hoods

    c) Safety plan

  • 86

    Which is NOT nontreponemal tests? 1. FTA-ABS 2. VDRL 3. RPR 4. MHA-TP 5. RST 6. USR 7. TRUST * 0/1 a) 2 and 4 b) 2 and 3 c) 1 and 7 d) 1 and 4

    d) 1 and 4

  • 87

    The required tests for the disease transmission prevention, EXCEPT? * 1/1 a) Tuberculosis b) HIV c) Malaria d) Syphilis

    a) Tuberculosis

  • 88

    How much anticoagulant is needed for 280 mL sample? * 0/1 a) 28 mL b) 39 mL c) 63 mL d) 70 mL

    b) 39 mL

  • 89

    What is the simplest test to evaluate the cellular immune system in a patient? * 0/1 a) Skin test b)Immunoelectrophoresis c) Protein electrophoresis d) Antibody titer

    a) Skin test

  • 90

    Which blood type can produced all FOUR blood types * 1/1 a) AA and BB b) AB and BO c) AB and AB d) BB and O

    b) AB and BO

  • 91

    Component of humoral immunity * 0/1 a) Antibodies b) Saliva c) T cell d) B cell

    a) Antibodies

  • 92

    Recombinant DNA techniques: * 0/1 a) Are not used in a clinical setting b) Are useful research tools c) Are not used in blood banking d) Are useful only for research

    d) Are useful only for research

  • 93

    nti-U will not react with which of the following RBCs? * 0/1 a)M+N+S+s– b)M+N–S–s– c)M–N+S–s+ d) M+N–S+s+

    b)M+N–S–s–

  • 94

    Can you accurately interpret a patient’s group AB, D- positive result in ABO and D typing tests using monoclonal antibody reagents without additional testing? * 0/1 a) YES b) NO c) Either d) Cannot be determine

    b) NO

  • 95

    What lectin possesses the specificity for the H antigen? * 1/1 a) Iberis amara b) Dolichos biflorus c) Ulex europaeus d) Vicia graminea

    c) Ulex europaeus

  • 96

    What is the term that describes the number of cases of a disease present in a particular population at a given time? * 0/1 a) Incidence b) Prevalence c) Case occurrence d) Window period

    b) Prevalence

  • 97

    What labile coagulation factors are present in fresh frozen plasma (FFP)? 1. Factor V 2. Fibrinogen 3. Anti-hemophilic factor 4. Factor IX * 1/1 a) 1 and 2 b) 1 and 3 c) 2 and 3 d) 3 and 4

    b) 1 and 3

  • 98

    Protein A captures antibodies by binding to: * 1/1 a) Fab portion of immunoglobulin b) Fc portion of immunoglobulin c) Surface of test cells d) Surface of indicator cells

    b) Fc portion of immunoglobulin

  • 99

    How does irradiation affect the shelf-life of red blood cells? * 1/1 a) Irradiation has no effect on the shelf-life. b) The expiration date is 28 days from the date of irradiation or the original outdate, whichever is later. c) The expiration date is 28 days from the date of irradiation or the original outdate, whichever is sooner. d) The expiration date is 25 days from the date of irradiation

    c) The expiration date is 28 days from the date of irradiation or the original outdate, whichever is sooner.

  • 100

    Which patient does not need an irradiated component? * 0/1 a) Bone marrow transplant recipient b) Neonate weighing less than 1,200 g c) Adult receiving an RBC transfusion d) Adult receiving an RBC transfusion from a blood relative

    c) Adult receiving an RBC transfusion